Based on the information received at the completion of the clinical evaluation, there were reported evidence that supported the following case event.Clinical was able to confirm that a user-error (unintentional) of the suprarenal stent deployment behind the main body stent had a lost wire access during the implant procedure (off-label technique and troubleshooting maneuver).Patient had never returned for a follow up after the initial implant, but eventually returned to a different hospital a year after that to treat for urgent presentation of pain/claudication.During that follow up, the ct showed the suprarenal aortic extension had folded in on itself and was causing an occlusion of the aorta.The physician explanted the devices on 10/03/2017 and were discarded at the hospital.The patient was reported to be doing well post explant.In addition clinical also found bilateral iliac occlusions; aortic stenosis from cuff to right common iliac artery; left endarterectomy; re-implantation of the inferior mesenteric artery; procedure-related left femoral artery endarterectomy and seroma; and bacteremia from a urinary tract infection.Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the occlusion within the device (main body stent) and inadequate stent graft patency (cuff) was the unintentional user-error, which contributed to the main body stent collapse (buckling).The final patient disposition could not be determined due to the lack of relevant information surrounding the explant procedure; there has been no report of further negative patient sequelae.A review of the manufacturing lot confirmed all devices met specifications prior to release.The explanted devices will not be returned and no evaluation will be completed.These types of events will be monitored and trended as part of the quality system.
|